Get notified when BHR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Material Weakness (improved) — Material weakness disclosed in 2024 baseline has been remediated; current filing contains no material weakness disclosure.
- Impairment Charges (new) — Company recorded a $54.5 million impairment charge in 2025, whereas no impairment charges were recorded in 2024 or 2023.
revenue $704.0M, net income -$22.3M. Braemar explores sale, records impairment, sells two hotels, remediates control weakness
Filed March 12, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 12, 2025 · ~2 min read
Key Changes
-
high
Company exploring potential sale of entire business or individual assets; advisory termination fee disclosed (discounted to ). Board suspended 2026 dividend policy citing ongoing sale process.
Notes: Advisory Agreement & Risk Factors: Strategic Transaction verify on EDGAR → -
high
Recorded impairment charge across three hotels (Sofitel Chicago, Hotel Yountville, Bardessono ) due to reduced expected holding periods, signaling potential near-term dispositions.
MD&A: Impairment Charges & Notes verify on EDGAR → -
high
Portfolio contracted from 15 to 13 hotels via sale of Marriott Seattle Waterfront (August 2025) and The Clancy (November 2025, ); repaid mortgage debt. Total room count fell from 3,807 to 3,028.
Business: Portfolio & Notes: Dispositions verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TLRY 10-Q) is open in full — no account needed.
Partner
Trade BHR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify